13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 3 managers

Reported value

$1.94M

Holders

3

+0 new · −0 exited

Holders’ est. mark

$790.6K

Price effect on 3 books still in the name

Largest holder

$1.62M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC53.8K$1.62M$856.6KCut−$96.9K
Henshaw Capital LLC10.2K$306.2K−$62.8KCut−$62.8K
Leonteq Securities AG520$15.6K−$3.21KCut−$3.21K

Who left

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.